USGLX | VIGRX | USGLX / VIGRX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 29 years | 32 years | - |
Gain YTD | 3.159 | 34.226 | 9% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.03B | 282B | 1% |
Annual Yield % from dividends | 0.00 | 0.43 | - |
Returns for 1 year | 3.72 | 34.33 | 11% |
Returns for 3 years | -4.78 | 32.78 | -15% |
Returns for 5 years | 24.57 | 129.76 | 19% |
Returns for 10 years | 59.08 | 298.30 | 20% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETIHX | 33.68 | 0.48 | +1.45% |
Eventide Healthcare & Life Sciences I | |||
GSVUX | 16.73 | 0.19 | +1.15% |
Goldman Sachs Large Cap Value R6 | |||
MLPSX | 88.38 | 0.73 | +0.83% |
ProFunds Mid Cap Value Svc | |||
FCDIX | 37.57 | 0.22 | +0.59% |
Fidelity Advisor Stock Selector Sm Cp I | |||
JHJIX | 23.00 | -1.97 | -7.88% |
JHancock ESG Large Cap Core I |